Eiger BioPharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$28.0M

377 transactions

Summary

Eiger BioPharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $15.2MSales: $9.9M52 insiders

Date	Insider	Type	Value
2023-10-31	KAYNE RICHARD A	Buy	$31K
2023-11-01	KAYNE RICHARD A	Buy	$28K
2023-11-02	KAYNE RICHARD A	Buy	$7K
2023-10-31	KAWAS LEEN	Buy	$3K
2023-10-31	KAYNE RICHARD A	Buy	$3K
2023-10-31	KAWAS LEEN	Buy	$3K
2023-10-31	KAYNE RICHARD A	Buy	$3K
2023-03-17	Mayer Eldon C. III(Ex VP & Chief Commerc. Officer)	Sell	$3K
2023-03-17	Mayer Eldon C. III(Ex VP & Chief Commerc. Officer)	Sell	$2K
2023-08-31	Choong Ingrid(Chief Business Officer)	A	$0
2023-07-03	Apelian David(CEO)	A	$0
2023-04-30	Vollins James(General Counsel)	A	$0
2023-03-01	Dietz Thomas John	A	$0
2023-03-01	Mayer Eldon C. III(Ex VP & Chief Commerc. Officer)	A	$0
2023-03-01	Kelly-Croswell Lisa	A	$0
2023-03-01	Sablich Kim	A	$0
2023-03-01	Glenn Jeffrey S	A	$0
2023-03-01	Murray Christine	A	$0
2023-03-01	Loh Evan	A	$0
2023-03-01	Sachdev Amit	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Eiger BioPharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope